Es gab 50 kürzliche Insider-Transaktionen für Sio Gene Therapies Inc. (SIOX), darunter 29 Käufe und 11 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $24.85M und die gesamten Insider-Verkäufe auf $609.68K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Nassif David W., Meswani Parag V, Cheruvu Pavan. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — SIOX
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2022-02-08 |
Nassif David W. |
Interim CEO, CFO |
RSU-Zuteilung |
546,500 |
- |
- |
546,500 |
| 2022-02-08 |
Meswani Parag V |
Chief Commercial Officer |
RSU-Zuteilung |
153,700 |
- |
- |
153,700 |
| 2022-01-28 |
Meswani Parag V |
Chief Commercial Officer |
Veräußerung |
219,000 |
$2.47 |
$540.93K |
- |
| 2021-12-08 |
Nassif David W. |
Chief Financial Officer |
Aktienrückgabe |
17,534 |
- |
- |
35,066 |
| 2021-12-08 |
Cheruvu Pavan |
Chief Executive Officer |
Aktienrückgabe |
37,567 |
- |
- |
75,133 |
| 2021-04-15 |
Vuori Kristiina Md |
Director |
RSU-Zuteilung |
42,000 |
$2.47 |
$103.74K |
42,000 |
| 2021-04-15 |
Nassif David W. |
Chief Financial Officer |
RSU-Zuteilung |
239,000 |
$2.47 |
$590.33K |
239,000 |
| 2021-04-15 |
Pande Atul |
Director |
RSU-Zuteilung |
42,000 |
$2.47 |
$103.74K |
42,000 |
| 2021-04-15 |
Modig Berndt |
Director |
RSU-Zuteilung |
42,000 |
$2.47 |
$103.74K |
42,000 |
| 2021-04-15 |
Torti Frank |
Director |
RSU-Zuteilung |
42,000 |
$2.47 |
$103.74K |
42,000 |
| 2021-04-15 |
Cheruvu Pavan |
Chief Executive Officer |
RSU-Zuteilung |
682,100 |
$2.47 |
$1.68M |
682,100 |
| 2021-04-15 |
Corcoran Gavin |
Chief R&d Officer |
RSU-Zuteilung |
244,300 |
$2.47 |
$603.42K |
244,300 |
| 2021-04-15 |
Sundaram Senthil Vel |
Director |
RSU-Zuteilung |
42,000 |
$2.47 |
$103.74K |
42,000 |
| 2021-03-23 |
Cheruvu Pavan |
Chief Executive Officer |
Informierter Kauf |
100,000 |
$2.48 |
$248.18K |
180,426 |
| 2021-03-22 |
Nassif David W. |
Chief Financial Officer |
Aktienrückgabe |
15,060 |
- |
- |
- |
| 2021-03-17 |
Cheruvu Pavan |
Chief Executive Officer |
Aktienrückgabe |
22,590 |
- |
- |
- |
| 2021-03-17 |
Corcoran Gavin |
Chief R&d Officer |
Aktienrückgabe |
16,001 |
- |
- |
- |
| 2020-11-24 |
Pande Atul |
Director |
Informierter Kauf |
10,000 |
$2.34 |
$23.4K |
33,370 |
| 2020-10-05 |
Vuori Kristiina Md |
Director |
Unbekannt |
- |
- |
- |
- |
| 2020-10-05 |
Vuori Kristiina Md |
Director |
RSU-Zuteilung |
35,000 |
$5.63 |
$197.05K |
35,000 |
| 2020-07-08 |
Pande Atul |
Director |
Informierter Kauf |
10,000 |
$2.73 |
$27.29K |
23,370 |
| 2020-07-08 |
Cheruvu Pavan |
Principal Executive Officer |
Informierter Kauf |
37,500 |
$2.74 |
$102.64K |
57,836 |
| 2020-06-12 |
Nassif David W. |
Principal Financial Officer |
Aktienrückgabe |
15,060 |
- |
- |
15,060 |
| 2020-06-12 |
Corcoran Gavin |
Chief R&d Officer |
RSU-Steuereinbehalt |
6,211 |
$3.46 |
$21.49K |
9,791 |
| 2020-06-11 |
Nassif David W. |
Principal Financial Officer |
RSU-Steuereinbehalt |
5,266 |
$3.25 |
$17.11K |
18,944 |
| 2020-06-11 |
Cheruvu Pavan |
Principal Executive Officer |
RSU-Steuereinbehalt |
9,755 |
$3.09 |
$30.14K |
20,336 |
| 2020-04-15 |
Nassif David W. |
Principal Financial Officer |
RSU-Zuteilung |
52,600 |
- |
- |
52,600 |
| 2020-04-15 |
Pande Atul |
Director |
RSU-Zuteilung |
17,500 |
$3.45 |
$60.38K |
17,500 |
| 2020-04-15 |
Modig Berndt |
Director |
RSU-Zuteilung |
17,500 |
$3.45 |
$60.38K |
17,500 |
| 2020-04-15 |
Torti Frank |
Director |
RSU-Zuteilung |
17,500 |
$3.45 |
$60.38K |
17,500 |
| 2020-04-15 |
Cheruvu Pavan |
Principal Executive Officer |
RSU-Zuteilung |
112,700 |
- |
- |
112,700 |
| 2020-04-15 |
Corcoran Gavin |
EVP of R&d |
RSU-Zuteilung |
42,400 |
- |
- |
42,400 |
| 2020-04-15 |
Sundaram Senthil Vel |
Director |
RSU-Zuteilung |
17,500 |
$3.45 |
$60.38K |
17,500 |
| 2020-03-16 |
Pande Atul |
Director |
Informierter Kauf |
10,000 |
$1.78 |
$17.84K |
13,370 |
| 2020-02-24 |
Roivant Sciences Ltd. |
10 Percent Owner |
Informierter Kauf |
5,333,333 |
$3.75 |
$20M |
18,577,380 |
| 2020-02-17 |
Venker Eric |
Director |
Unbekannt |
- |
- |
- |
- |
| 2019-09-21 |
Nassif David W. |
Principal Financial Officer |
RSU-Zuteilung |
30,120 |
- |
- |
30,120 |
| 2019-09-21 |
Cheruvu Pavan |
Principal Executive Officer |
RSU-Zuteilung |
45,181 |
- |
- |
45,181 |
| 2019-09-21 |
Corcoran Gavin |
EVP of R&d |
RSU-Zuteilung |
32,003 |
- |
- |
32,003 |
| 2019-07-10 |
Viking Global Investors Lp |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2019-07-10 |
Viking Global Performance Llc |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2019-07-10 |
Qvt Associates Gp Llc |
10 Percent Owner |
Unbekannt |
- |
- |
- |
- |
| 2019-07-10 |
Dexxon Holdings Ltd. |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2019-07-10 |
Svf Investments (uk) Ltd |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2019-07-10 |
Machado Patrick |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2019-07-10 |
Lo Andrew |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2019-07-01 |
Nassif David W. |
Principal Financial Officer |
Veräußerung |
- |
- |
- |
9,150 |
| 2019-07-01 |
Nassif David W. |
Principal Financial Officer |
RSU-Zuteilung |
75,000 |
$6.42 |
$481.5K |
75,000 |
| 2019-06-27 |
Sundaram Senthil Vel |
Director |
Unbekannt |
- |
- |
- |
- |
| 2019-06-27 |
Sundaram Senthil Vel |
Director |
RSU-Zuteilung |
18,750 |
$6.19 |
$116.06K |
18,750 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall